Skip to content
Living
GLP1
Findings
Treatments
Trials
NMA lab
Protocol
Inventory
Methods
Learn
Data
Home
/
Treatments
/
Mari sc 21mg other
GIP receptor antagonist and GLP-1 receptor agonist
Mari sc 21mg other
MARI_SC_21MG_OTHER
Mechanism
Antibody peptide conjugate (maridebart cafraglutide)
Trials
0
Participants in these arms
0
Related
All doses pooled: Mari sc
Maridebart cafraglutide 280 mg injection every 4 weeks
Maridebart cafraglutide 420 mg injection every 4 weeks
Mari sc 70mg other
Mari sc 140mg other
Mari sc 280mg other
Mari sc 560mg other
Mari sc 840mg other
Maridebart cafraglutide 140 mg injection every 4 weeks
Trials